These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 32807036)
1. Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats. Sammarco A; Gomiero C; Sacchetto R; Beffagna G; Michieletto S; Orvieto E; Cavicchioli L; Gelain ME; Ferro S; Patruno M; Zappulli V Vet Pathol; 2020 Nov; 57(6):774-790. PubMed ID: 32807036 [TBL] [Abstract][Full Text] [Related]
2. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours. Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094 [TBL] [Abstract][Full Text] [Related]
3. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours. Rico C; Boerboom D; Paquet M Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264 [TBL] [Abstract][Full Text] [Related]
4. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis. Li H; Gumbiner BM Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049 [TBL] [Abstract][Full Text] [Related]
5. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade. Budel SJ; Penning MM; Penning LC Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors. Guillemette S; Rico C; Godin P; Boerboom D; Paquet M J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004 [TBL] [Abstract][Full Text] [Related]
7. Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumour cells. Vigneau AL; Rico C; Boerboom D; Paquet M Vet Comp Oncol; 2022 Jun; 20(2):437-448. PubMed ID: 34881506 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of expression of the Wnt signaling components in canine mammary tumors via RT Yu F; Rasotto R; Zhang H; Pei S; Zhou B; Yang X; Jin Y; Zhang D; Lin D J Vet Sci; 2017 Sep; 18(3):359-367. PubMed ID: 27586466 [TBL] [Abstract][Full Text] [Related]
9. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer. Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471 [TBL] [Abstract][Full Text] [Related]
10. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways]. Xu F; Zhang J; Ma D Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer. Atmane MI; Vigneau AL; Beaudry F; Rico C; Boerboom D; Paquet M Vet Comp Oncol; 2023 Dec; 21(4):634-645. PubMed ID: 37709554 [TBL] [Abstract][Full Text] [Related]
12. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation. Kim W; Khan SK; Yang Y BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216 [TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors. Sammarco A; Gomiero C; Beffagna G; Cavicchioli L; Ferro S; Michieletto S; Orvieto E; Patruno M; Zappulli V Animals (Basel); 2023 Feb; 13(5):. PubMed ID: 36899736 [TBL] [Abstract][Full Text] [Related]
14. Wnt/β-Catenin Signaling Regulates Yap/Taz Activity during Embryonic Development in Zebrafish. Astone M; Tesoriero C; Schiavone M; Facchinello N; Tiso N; Argenton F; Vettori A Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337493 [TBL] [Abstract][Full Text] [Related]
15. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis. Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019. Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N PeerJ; 2024; 12():e17077. PubMed ID: 38500523 [TBL] [Abstract][Full Text] [Related]
17. Mammalian sterile 20-like kinase 1/2 inhibits the Wnt/β-catenin signalling pathway by directly binding casein kinase 1ε. Xu F; Wang YL; Chang JJ; Du SC; Diao L; Jiang N; Wang HJ; Ma D; Zhang J Biochem J; 2014 Feb; 458(1):159-69. PubMed ID: 24180524 [TBL] [Abstract][Full Text] [Related]
18. Crosslinked Extracellular Matrix Stiffens Human Trabecular Meshwork Cells Via Dysregulating β-catenin and YAP/TAZ Signaling Pathways. Yemanyi F; Vranka J; Raghunathan VK Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):41. PubMed ID: 32832971 [TBL] [Abstract][Full Text] [Related]
19. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. Imajo M; Miyatake K; Iimura A; Miyamoto A; Nishida E EMBO J; 2012 Mar; 31(5):1109-22. PubMed ID: 22234184 [TBL] [Abstract][Full Text] [Related]
20. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells. Cao X; Zhao B Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]